Fresh woes emerge as Teva plunges to new lows - Globes
Fallout from Teva plant closings, global layoffs continues in Israel | Fierce Pharma
Teva share price jumps 55% in past three weeks - Globes
Teva reports heavy losses, sees minimal 2023 growth - Globes
Teva Pharma Buys Smart Inhaler Company Gecko Health | RT
Teva agrees to tentative $4.25 billion national settlement over opioids - The Boston Globe
Analysts see upside in Teva share price - גלובס
Teva expands sustainability notes issue to $5b - גלובס
Teva Pharmaceutical CEO Schultz stepping down in November 2023 - WSJ (TEVA) | Seeking Alpha
Teva stocks fall after company said named in US price-fixing drug 'cartel' probe | The Times of Israel
Teva recalls US-made drugs following contamination fears - The Boston Globe
Teva Pharmaceuticals - Wikipedia
Israel sues Teva for $100m Copaxone royalties - Globes
Teva Pharmaceutical Paying $519 Million to Settle FCPA Charges
Teva misses on Q3 profit and revenue - Globes
Teva completes $40b purchase of Allergan generics arm | The Times of Israel
Teva targets sub-Saharan Africa - Globes
Just 10% of Teva's employees located in Israel - Globes
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Teva to build new headquarters in Tel Aviv - Globes
With $40 million pay, Teva breaks from custom for turnaround - The Boston Globe
Teva keeps 2020 guidance unchanged despite virus crisis - Globes
